Product Comparison


 
Merck 00006404741
Merck 00006404720
Glaxo Smith Kline 58160085452
McKesson # 544446 1030987 775513
Description RotaTeq® Rotavirus Vaccine 6 to 32 Weeks of Age Suspension Single Dose Tube 2 mL RotaTeq® Rotavirus Vaccine Indicated for Patients 6 to 32 Weeks of Age Solution Single Dose Tube 2 mL Rotarix® Rotavirus Vaccine Infants 6 to 24 Weeks of Age 10E6 / mL Suspension Prefilled Oral Applicator 1 mL
Manufacturer # 000064047410000640472058160085452
Brand RotaTeq®RotaTeq®Rotarix®
Manufacturer MerckMerckGlaxo Smith Kline
Invoice ROTATEQ VAC, SUSP 2ML LIVE PENTAV (10/PK)ROTATEQ VAC, SUSP 2ML LIVE PENTAV (25/BX)ROTARIX VACCINE, ORAL SUSP 10E6/ML 1ML (10/PK)
    Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 3466471
Container Type Single Dose TubeSingle Dose TubePrefilled Oral Applicator
Country of Origin United StatesUnited StatesUnknown
Dosage Form SuspensionSolutionSuspension
Generic Drug Code 265002650027017
Generic Drug Name Rotavirus Vaccine, Live, PentavalentRotavirus Vaccine, Live, Oral PentavalentRotavirus Vaccine, Live Attenuated, 89-12, Preservative Free
NDC Number 0000640474100006-4047-2058160085452
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 180 days
Strength 10E6 / mL
Type OralUnit Dose, OralOral
User 6 to 32 Weeks of AgeIndicated for Patients 6 to 32 Weeks of AgeInfants 6 to 24 Weeks of Age
Volume 2 mL2 mL1 mL
Application Rotavirus VaccineRotavirus VaccineRotavirus Vaccine
Storage Requirements Requires RefrigerationRequires RefrigerationRequires Refrigeration
UNSPSC Code 512016185120161851201618
Features and Benefits
  • The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
  • 10 individually pouched single dose tubes
  • Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
  • RotaTeq® is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by types G1, G2, G3, G4, and G9
  • RotaTeq is approved for use in infants 6 weeks to 32 weeks of age
  • The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
  • Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
  • The dosing tube is contained in a pouch
  • Package of 25 individually pouched single-dose tubes
  • Administer first dose to infants beginning at 6 weeks of age
  • Administer second dose after an interval of at least 4 weeks and prior to 24 weeks of age
  • Vial of lyophilized vaccine to be reconstituted with accompanying liquid diluent in a prefilled oral applicator
  • Includes a prefilled oral applicator of liquid diluent with a plunger stopper
  • Includes a transfer adapter for reconstitution
  • Store lyophilized vaccine refrigerated between 2 and 8 degrees C (36 and 46 degrees F)
  • Diluent may be stored at controlled room temperature